Salem Capital Management Inc Novartis Ag Transaction History

Salem Capital Management Inc

$126 Million
Q3 2022

A detailed history of Salem Capital Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Salem Capital Management Inc holds 16,377 shares of NVS stock, worth $1.7 Million. This represents 0.99% of its overall portfolio holdings.

Number of Shares

16,377

Previous 16,577 1.21%

Holding current value

$1.7 Million

Previous $1.4 Million 11.13%

% of portfolio

0.99%

Previous 1.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 29, 2022	SELL	$74.61 - $87.26 $14,922 - $17,452	-200 Reduced 1.21%	16,377 $1.25 Million
Q2 2022 Jul 27, 2022	SELL	$80.52 - $93.75 $275,136 - $320,343	-3,417 Reduced 17.09%	16,577 $1.4 Million
Q4 2021 Jan 18, 2022	SELL	$79.7 - $88.13 $856,775 - $947,397	-10,750 Reduced 34.97%	19,994 $1.75 Million
Q3 2021 Oct 12, 2021	BUY	$81.78 - $95.14 $1.8 Million - $2.09 Million	22,000 Added 251.6%	30,744 $2.51 Million
Q2 2021 Jul 13, 2021	BUY	$85.24 - $94.15 $25,572 - $28,245	300 Added 3.55%	8,744 $798,000
Q1 2020 Apr 14, 2020	SELL	$70.67 - $99.01 $63,603 - $89,109	-900 Reduced 9.63%	8,444 $696,000
Q1 2019 Apr 15, 2019	SELL	$75.32 - $86.15 $42,103 - $48,157	-559 Reduced 5.64%	9,344 $898,000
Q4 2018 Jan 08, 2019	SELL	$73.66 - $82.02 $8,544 - $9,514	-116 Reduced 1.16%	9,903 $850,000
Q3 2018 Oct 09, 2018	BUY	$66.94 - $77.43 $16,132 - $18,660	241 Added 2.46%	10,019 $863,000
Q2 2018 Jul 09, 2018	SELL	$64.91 - $73.36 $32,584 - $36,826	-502 Reduced 4.88%	9,778 $739,000
Q1 2018 Apr 09, 2018	SELL	$70.39 - $84.15 $12,318 - $14,726	-175 Reduced 1.67%	10,280 $831,000
Q4 2017 Jan 16, 2018	BUY	$72.33 - $77.64 $12,657 - $13,587	175 Added 1.7%	10,455 $878,000
Q3 2017 Oct 10, 2017	BUY	$74.14 - $77.27 $762,159 - $794,335	10,280	10,280 $883,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Capital Management Inc with notifications on news.

Account

Salem Capital Management Inc Novartis Ag Transaction History